Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Leukemia × Mitoxantrone × Clear all

Phase

Phase 2 18 Phase 3 14 Phase 1 9 Phase 1/2 6 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1

Interventions

Cyclophosphamide 21 fludarabine phosphate 11 Cyclosporine 10 Cytarabine 9 Antilymphocyte Serum 9 Peripheral Blood Stem Cell Transplantation 8 Methotrexate 8 Busulfan 8 Radiotherapy 7 Filgrastim 7 Dexamethasone 7 Whole-Body Irradiation 6 Mycophenolic Acid 6 Melphalan 6 Exercise 6 fludarabine 5 Vincristine 5 Daunorubicin 5 Cord Blood Stem Cell Transplantation 5 pegaspargase 4 Rituximab 4 Palliative Care 4 Methylprednisolone 4 Mercaptopurine 4 Etoposide 4 Blood Specimen Collection 4 Asparaginase 4 Alemtuzumab 4 Thioguanine 3 Surveys and Questionnaires 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00550992 2019-07-30

Interfant06

Dutch Childhood Oncology Group

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡